Traws Pharma
TRAW
TRAW
19 hedge funds and large institutions have $1.87M invested in Traws Pharma in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
TSS
Two Sigma Securities
New York
|
+$25.4K |
2 |
Two Sigma Investments
New York
|
+$23.8K |
3 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.47K |
4 |
Raymond James Financial
St Petersburg,
Florida
|
+$151 |
5 |
Citigroup
New York
|
+$89 |
Top Sellers
1 |
PA
Perceptive Advisors
New York
|
-$970K |
2 |
BFM
Boothbay Fund Management
New York
|
-$76.6K |
3 |
VPC
Vestal Point Capital
New York
|
-$37.3K |
4 |
Millennium Management
New York
|
-$23.2K |
5 |
UBS Group
Zurich,
Switzerland
|
-$16.8K |